[ET Net News Agency, 10 May 2022] Macquarie lowered its target price for Innovent Bio
(01801) to HK$43.42 and maintained its "outperform" rating.
The research house said it is adjusting 2022E/2023E/2024E EPS -9%/4%/-3%, mainly due to
lower Tyvyt sales. (RC)